TERRY SAUNDERS

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical LOS ANGELES, CA NPI 1740301191

General Payments — all program years on this page

$2,030.73

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 81
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $855.64 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $855.6420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Gilead Sciences, Inc. $452.2310
ABBVIE INC. $213.886
GlaxoSmithKline, LLC. $147.592
Madrigal Pharmaceuticals $21.901
Merck Sharp & Dohme Corporation $20.041

By program year

Program yearAmountRecords
2021 $1,148.8160
2023 $26.281
2024 $855.6420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1108148343 ABBVIE INC. $124.99 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108148345 ABBVIE INC. $29.83 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108148347 ABBVIE INC. $23.49 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108148349 ABBVIE INC. $22.92 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108148351 ABBVIE INC. $2.71 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108148353 ABBVIE INC. $9.94 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116409451 GlaxoSmithKline, LLC. $121.82 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116682523 GlaxoSmithKline, LLC. $25.77 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731511 Gilead Sciences, Inc. $107.92 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731513 Gilead Sciences, Inc. $30.81 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731515 Gilead Sciences, Inc. $4.13 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731517 Gilead Sciences, Inc. $3.97 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731519 Gilead Sciences, Inc. $110.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731521 Gilead Sciences, Inc. $14.10 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731523 Gilead Sciences, Inc. $30.69 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731525 Gilead Sciences, Inc. $114.14 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731527 Gilead Sciences, Inc. $4.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133731529 Gilead Sciences, Inc. $32.07 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141600969 Merck Sharp & Dohme LLC $20.04 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144198455 Madrigal Pharmaceuticals $21.90 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.